# Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection

> **NCT02128217** · PHASE1 · COMPLETED · sponsor: **Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections** · enrollment: 44 (actual)

## Conditions studied

- HIV-1 Infection
- Hepatitis

## Interventions

- **DRUG:** Sofosbuvir
- **DRUG:** Ribavirin
- **DRUG:** Ledipasvir/Sofosbuvir

## Key facts

- **NCT ID:** NCT02128217
- **Lead sponsor:** Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-30
- **Primary completion:** 2017-02-28
- **Final completion:** 2017-05-09
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2018-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02128217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02128217, "Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02128217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*